These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20008917)

  • 21. Low dose methotrexate in the first trimester of pregnancy: results of a French collaborative study.
    Lewden B; Vial T; Elefant E; Nelva A; Carlier P; Descotes J;
    J Rheumatol; 2004 Dec; 31(12):2360-5. PubMed ID: 15570635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Smoking cessation and pregnancy].
    Møller AM; Tønnesen H
    Ugeskr Laeger; 1999 Sep; 161(36):4985-6. PubMed ID: 10489788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumour necrosis factor inhibitors: risks and benefits in patients with rheumatoid arthritis.
    Roberts L; McColl GJ
    Intern Med J; 2004 Dec; 34(12):687-93. PubMed ID: 15610214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety of anti-tumor necrosis factor-alpha therapy in patients with rheumatoid arthritis and chronic hepatitis C virus infection.
    Ferri C; Ferraccioli G; Ferrari D; Galeazzi M; Lapadula G; Montecucco C; Triolo G; Valentini G; Valesini G;
    J Rheumatol; 2008 Oct; 35(10):1944-9. PubMed ID: 18688917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical efficacy of infliximab plus methotrexate in DMARD naive and DMARD refractory rheumatoid arthritis is associated with decreased synovial expression of TNF alpha and IL18 but not CXCL12.
    van Oosterhout M; Levarht EW; Sont JK; Huizinga TW; Toes RE; van Laar JM
    Ann Rheum Dis; 2005 Apr; 64(4):537-43. PubMed ID: 15769913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Hyrich KL; Watson KD; Silman AJ; Symmons DP;
    Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infliximab treatment of rheumatoid arthritis and Crohn's disease.
    Nahar IK; Shojania K; Marra CA; Alamgir AH; Anis AH
    Ann Pharmacother; 2003 Sep; 37(9):1256-65. PubMed ID: 12921510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biologic therapies and pregnancy: the story so far.
    Hyrich KL; Verstappen SM
    Rheumatology (Oxford); 2014 Aug; 53(8):1377-85. PubMed ID: 24352337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-TNF therapy and pregnancy outcomes in women with inflammatory arthritis.
    Vinet E; Pineau C; Gordon C; Clarke AE; Bernatsky S
    Expert Rev Clin Immunol; 2009 Jan; 5(1):27-34. PubMed ID: 20476897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emerging data on the use of anti-tumor necrosis factor-alpha medications in pregnancy.
    Chambers CD; Johnson DL
    Birth Defects Res A Clin Mol Teratol; 2012 Aug; 94(8):607-11. PubMed ID: 22786755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Management of rheumatoid arthritis medications and pregnancy].
    Funakubo Asanuma Y
    Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(1):45-56. PubMed ID: 25765688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imaging of pregnant and lactating patients: part 1, evidence-based review and recommendations.
    Wang PI; Chong ST; Kielar AZ; Kelly AM; Knoepp UD; Mazza MB; Goodsitt MM
    AJR Am J Roentgenol; 2012 Apr; 198(4):778-84. PubMed ID: 22451541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A survey of inclusion of the time element when reporting adverse effects in randomised controlled trials of cyclo-oxygenase-2 and tumour necrosis factor alpha inhibitors.
    Yazici Y; Yazici H
    Ann Rheum Dis; 2007 Jan; 66(1):124-7. PubMed ID: 16831828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psoriasis in pregnancy: a review (II).
    Ruiz V; Manubens E; Puig L
    Actas Dermosifiliogr; 2014 Nov; 105(9):813-21. PubMed ID: 24314892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pregnancy outcome in women exposed to leflunomide before or during pregnancy.
    Cassina M; Johnson DL; Robinson LK; Braddock SR; Xu R; Jimenez JL; Mirrasoul N; Salas E; Luo YJ; Jones KL; Chambers CD;
    Arthritis Rheum; 2012 Jul; 64(7):2085-94. PubMed ID: 22307734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation.
    Götestam Skorpen C; Hoeltzenbein M; Tincani A; Fischer-Betz R; Elefant E; Chambers C; da Silva J; Nelson-Piercy C; Cetin I; Costedoat-Chalumeau N; Dolhain R; Förger F; Khamashta M; Ruiz-Irastorza G; Zink A; Vencovsky J; Cutolo M; Caeyers N; Zumbühl C; Østensen M
    Ann Rheum Dis; 2016 May; 75(5):795-810. PubMed ID: 26888948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety of TNF-α inhibitors during IBD pregnancy: a systematic review.
    Nielsen OH; Loftus EV; Jess T
    BMC Med; 2013 Jul; 11():174. PubMed ID: 23902720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Biologics during pregnancy and breast--feeding].
    Fischer-Betz RE; Schneider M
    Z Rheumatol; 2010 Nov; 69(9):780-7. PubMed ID: 21063826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Meta-Analysis of Pregnancy Outcomes after Exposure to TNF-α Inhibitors During Pregnancy for the Treatment of Arthritic Diseases.
    Mirdamadi K; Salinas T; Vali R; Papadimitropoulos M; Piquette-Miller M
    J Popul Ther Clin Pharmacol; 2018 Apr; 25(1):e53-e56. PubMed ID: 29949681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pregnancy outcome in women who were exposed to anti-tumor necrosis factor agents: results from a national population register.
    Hyrich KL; Symmons DP; Watson KD; Silman AJ;
    Arthritis Rheum; 2006 Aug; 54(8):2701-2. PubMed ID: 16871549
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.